Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Alan Ezekowitz currently holds 15,000 shares of Fulcrum Therapeutics, Inc. (FULC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alan Ezekowitz has been a net neutral trader of FULC stock. They have purchased $0 and sold $0 worth of shares.
Alan Ezekowitz's most recent insider trade was on Jun 26, 2026, when they sold 15,000 shares at $0.00 per share.
Alan Ezekowitz serves as Executive at Fulcrum Therapeutics, Inc. (FULC). They have executed 3 insider transactions totaling $0 over their tenure at the company.
Alan Ezekowitz holds the position of Executive at Fulcrum Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Alan Ezekowitz has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Alan Ezekowitz was on Jun 7, 2024, when they purchased $200.0K worth of OGN shares. This transaction involved 9,638.55 shares at $20.75 per share.
Alan Ezekowitz currently owns 15,000 shares of Fulcrum Therapeutics, Inc. (FULC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Alan Ezekowitz's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Alan Ezekowitz has 3 Form 4 filings on record as an insider at Fulcrum Therapeutics, Inc..
Set alerts for Alan Ezekowitz and 40,000+ other insiders.